Acute psychosis after mefloquine. Report of six cases. 1995

A Sowunmi, and R A Adio, and A M Oduola, and O A Ogundahunsi, and L A Salako
Department of Pharmacology and Therapeutics, University of Ibadan, Nigeria.

A self-limiting psychosis characterized by acute onset of visual and auditory hallucinations and poor sleep developed in six adults between 8 and 24 hours after oral administration of 750-1500 mg of the antimalarial mefloquine. All patients had no personal or family history of psychosis and were neurologically and mentally normal before mefloquine ingestion. These cases illustrate that acute psychotic symptoms may occur in patients treated with mefloquine.

UI MeSH Term Description Entries
D008297 Male Males
D011605 Psychoses, Substance-Induced Psychotic organic mental disorders resulting from the toxic effect of drugs and chemicals or other harmful substance. Psychoses, Drug,Psychoses, Toxic,Substance-Induced Psychoses,Toxic Psychoses,Drug Psychoses,Psychoses, Substance Induced,Substance Induced Psychoses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000962 Antimalarials Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) Anti-Malarial,Antimalarial,Antimalarial Agent,Antimalarial Drug,Anti-Malarials,Antimalarial Agents,Antimalarial Drugs,Agent, Antimalarial,Agents, Antimalarial,Anti Malarial,Anti Malarials,Drug, Antimalarial,Drugs, Antimalarial
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D015767 Mefloquine A phospholipid-interacting antimalarial drug (ANTIMALARIALS). It is very effective against PLASMODIUM FALCIPARUM with very few side effects. Lariam,Mefloquine Hydrochloride,Mephloquine,Ro-21-5998-001,WR-142,490,WR-177,602,Ro 21 5998 001,Ro215998001,WR 142,490,WR 177,602,WR142,490,WR177,602

Related Publications

A Sowunmi, and R A Adio, and A M Oduola, and O A Ogundahunsi, and L A Salako
December 1994, East African medical journal,
A Sowunmi, and R A Adio, and A M Oduola, and O A Ogundahunsi, and L A Salako
July 1989, Lancet (London, England),
A Sowunmi, and R A Adio, and A M Oduola, and O A Ogundahunsi, and L A Salako
October 1989, Lancet (London, England),
A Sowunmi, and R A Adio, and A M Oduola, and O A Ogundahunsi, and L A Salako
April 1996, Canadian journal of psychiatry. Revue canadienne de psychiatrie,
A Sowunmi, and R A Adio, and A M Oduola, and O A Ogundahunsi, and L A Salako
July 1991, Journal of neurology, neurosurgery, and psychiatry,
A Sowunmi, and R A Adio, and A M Oduola, and O A Ogundahunsi, and L A Salako
August 2006, Malaria journal,
A Sowunmi, and R A Adio, and A M Oduola, and O A Ogundahunsi, and L A Salako
September 1999, Psychiatrische Praxis,
A Sowunmi, and R A Adio, and A M Oduola, and O A Ogundahunsi, and L A Salako
February 2000, The Pediatric infectious disease journal,
A Sowunmi, and R A Adio, and A M Oduola, and O A Ogundahunsi, and L A Salako
June 1996, Annals of emergency medicine,
A Sowunmi, and R A Adio, and A M Oduola, and O A Ogundahunsi, and L A Salako
April 1992, Diseases of the colon and rectum,
Copied contents to your clipboard!